Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELPHI: Atorvastatin for Intermediate AMD
NCT04735263Phase 2Recruiting
- Sponsor
- Massachusetts Eye and Ear
- Start
- Feb 2021
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in age-related macular degeneration (AMD), sponsored by Massachusetts Eye and Ear. Started Feb 2021; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT04735263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04735263.